Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of BOTOX and Dysport in Cervical Dystonia
2006-006449-14Phase 4Completed
- Sponsor
- Allergan
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in cervical dystonia (CD) (2 arms), sponsored by Allergan. Primary endpoint: Incidence and severity of dysphagia. Started Aug 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2006-006449-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006449-14.